Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17135217rdf:typepubmed:Citationlld:pubmed
pubmed-article:17135217lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17135217lifeskim:mentionsumls-concept:C0025815lld:lifeskim
pubmed-article:17135217lifeskim:mentionsumls-concept:C0024143lld:lifeskim
pubmed-article:17135217lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:17135217lifeskim:mentionsumls-concept:C0004482lld:lifeskim
pubmed-article:17135217lifeskim:mentionsumls-concept:C0010583lld:lifeskim
pubmed-article:17135217lifeskim:mentionsumls-concept:C0391850lld:lifeskim
pubmed-article:17135217lifeskim:mentionsumls-concept:C0334094lld:lifeskim
pubmed-article:17135217lifeskim:mentionsumls-concept:C0033522lld:lifeskim
pubmed-article:17135217lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:17135217pubmed:issue5lld:pubmed
pubmed-article:17135217pubmed:dateCreated2007-4-30lld:pubmed
pubmed-article:17135217pubmed:abstractTextTo study the prevalence and course of anti-chromatin (anti-nucleosome, anti-double-stranded (ds) DNA and anti-histone) and anti-C1q autoantibodies in patients with proliferative lupus nephritis (LN), treated in a randomised controlled trial with either cyclophosphamide or azathioprine plus methylprednisolone.lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:languageenglld:pubmed
pubmed-article:17135217pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:citationSubsetIMlld:pubmed
pubmed-article:17135217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17135217pubmed:statusMEDLINElld:pubmed
pubmed-article:17135217pubmed:monthMaylld:pubmed
pubmed-article:17135217pubmed:issn0003-4967lld:pubmed
pubmed-article:17135217pubmed:authorpubmed-author:DahaMohamed...lld:pubmed
pubmed-article:17135217pubmed:authorpubmed-author:RoosAnjaAlld:pubmed
pubmed-article:17135217pubmed:authorpubmed-author:DerksenRonald...lld:pubmed
pubmed-article:17135217pubmed:authorpubmed-author:BerdenJo H...lld:pubmed
pubmed-article:17135217pubmed:authorpubmed-author:Grootscholten...lld:pubmed
pubmed-article:17135217pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:17135217pubmed:authorpubmed-author:DiekerJürgen...lld:pubmed
pubmed-article:17135217pubmed:authorpubmed-author:McGrathFabian...lld:pubmed
pubmed-article:17135217pubmed:issnTypePrintlld:pubmed
pubmed-article:17135217pubmed:volume66lld:pubmed
pubmed-article:17135217pubmed:ownerNLMlld:pubmed
pubmed-article:17135217pubmed:authorsCompleteYlld:pubmed
pubmed-article:17135217pubmed:pagination693-6lld:pubmed
pubmed-article:17135217pubmed:dateRevised2010-9-14lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:meshHeadingpubmed-meshheading:17135217...lld:pubmed
pubmed-article:17135217pubmed:year2007lld:pubmed
pubmed-article:17135217pubmed:articleTitleA prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone.lld:pubmed
pubmed-article:17135217pubmed:affiliationDivision of Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.lld:pubmed
pubmed-article:17135217pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17135217pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:17135217pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17135217lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17135217lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17135217lld:pubmed